W. Thomas Mueller
Pfizer (United States)(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Biochemical and Molecular Research, Enzyme Structure and Function, HIV/AIDS drug development and treatment, Chemical Synthesis and Analysis
Most-Cited Works
- → Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition(2004)614 cited
- → HTLV-III/LAV-Neutralizing Antibodies to an E. coli -Produced Fragment of the Virus Envelope(1986)332 cited
- → Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects(2007)209 cited
- → A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore(2009)159 cited
- → Regulatory Effects of Endogenous Protease Inhibitors in Acute Lung Inflammatory Injury(1999)101 cited
- → Characterization of the enzyme complex involving the folate-requiring enzymes of de novo purine biosynthesis(1980)84 cited
- → Engineering subtilisin for reaction in dimethylformamide(1991)81 cited
- → On the purification and mechanism of action of 5-aminoimidazole-4-carboxamide-ribonucleotide transformylase from chicken liver(1981)60 cited
- → On the cofactor specificity of glycinamide ribonucleotide and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase from chicken liver(1981)59 cited
- → Design, Synthesis, and Cocrystal Structure of a Nonpeptide Src SH2 Domain Ligand(1997)48 cited